uniQure N.V. Ordinary Shares vs Sotera Health Company Common Stock — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while Sotera Health Company Common Stock trades at $17.68 (market cap $5.20B). The key difference: Sotera Health Company Common Stock is far larger — about 3.5× uniQure N.V. Ordinary Shares's market cap, and Sotera Health Company Common Stock is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Sotera Health Company Common Stock for 0 Days on average.
| QURE | SHC | |
|---|---|---|
Market Cap | $1.48B | $5.20B |
Volume | 2,488,780 | 1,647,777 |
Sector | Health | Health |
52-Week High | $70.59 | $19.57 |
52-Week Low | $9.03 | $13.13 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $728.62M | $7.11B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →Sotera Health Company is a US provider of sterilization and lab testing services for the healthcare industry, operating through its Sterigenics, Nordion, and Nelson Labs businesses.
Read more on SHC →